SHIKARI® Q-DEN

Enzyme immunoassay for the quantitative determination of denosumab (Prolia®) in serum and plasma.

Matriks Biotek denosumab ELISA has been especially developed for the quantitative analysis of denosumab in serum and plasma samples between the Cmin and Cmax range of concentrations indicated in the pharmacokinetics section of prospectus.



Click the diagram to see bigger

about-me





Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 3
Spike Recovery (%) Between 85-115
Shelf Life (year) 1

SHIKARI® S-ATD

Enzyme immunoassay for the qualitative determination (screening) of antibodies to denosumab (Prolia®) in serum and plasma.

The Matriks Biotek Antibody to denosumab (Prolia®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to denosumab (Prolia®) in serum and plasma. It is for professional use only.





Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87